1 / 10

Global Liquid Biopsy Market | Industry, Trends, Analysis 2018-2026

The Global Liquid Biopsy market is anticipated to grow at a CAGR of 22.97% between 2018 and 2026. Get 10% free customization on your first purchase!

inkwoodresearch
Télécharger la présentation

Global Liquid Biopsy Market | Industry, Trends, Analysis 2018-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Liquid Biopsy Market Forecast 2018-2026

  2. Agenda Regional Insights Key Findings Market Insights Competitive Insights

  3. Key Findings Left Image Slide Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for 'lorem ipsum' will uncover many web sites still in their infancy. Various versions have evolved. • Developments in precision medicines, increasing prevalence of cancer cases in the elderly population and supportive government initiatives are factors that are contributing to the expansion of the Liquid –Biopsy market. • Over the forecast period of 2018-2026, the global liquid biopsy market is expected to rise at a CAGR of 22.97%.

  4. Market Insights The Global Liquid Biopsy market is segmented into Biomarker types, Indication, Analysis Platform, Products, Analysis purpose, and End users. The biomarker types includenucleic acids, proteins, extracellular vesicles and cells. The Indication segment of the market can further be classified cancer indications, NIPT, and Transplant. The analysis platform of this market includes Microarray, NGS, Proteomics, PCR, and other analysis platform. The products for this market can be further classified into exosomes, CTCS and CTDNA products. The Analysis purpose for this market is for Therapy guidance, early detection/screening, monitoring and diagnosis. The end-users for this market are Hospitals, Physicians ‘office laboratories’, and Clinical diagnostic laboratories.

  5. Image Slide Lorem Ipsum Lorem Ipsum Lorem Ipsum Lorem Ipsum Lorem Ipsum Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

  6. The Global Liquid Biopsy Market is expected to rise at a CAGR of 22.97%, over the forecast period of 2018-2026. Request Free Sample

  7. Competitive Insights Some of the leading market players in the global liquid biopsy market are Agilent Technologies Inc, Ad-Tech Medical Instrument Corp, Argon Medical Devices Inc, Becton, B. Braun Melsungen Ag, Dickinson, Bio-Rad Laboratories Inc, Boston Scientific Corporation, C. R. Bard, Inc, Cook Group Inc, Cintec Medical Ltd, Fischer Medical Technologies Llc, Planmeca Oy, I.M.S. Internazionale Medico ScientificaSrl,Roche Diagnostics Ltd, andQiagen N.V.

More Related